Literature DB >> 33086432

Analyzing left-truncated and right-censored infectious disease cohort data with interval-censored infection onset.

Daewoo Pak1,2, Jun Liu3, Jing Ning2, Guadalupe Gómez4, Yu Shen2.   

Abstract

In an infectious disease cohort study, individuals who have been infected with a pathogen are often recruited for follow up. The period between infection and the onset of symptomatic disease, referred to as the incubation period, is of interest because of its importance on disease surveillance and control. However, the incubation period is often difficult to ascertain due to the uncertainty associated with asymptomatic infection onset time. An additional complication is that the observed infected subjects are likely to have longer incubation periods due to the prevalent sampling. In this article, we demonstrate how to estimate the distribution of the incubation period with the uncertain infection onset, subject to left-truncation and right-censoring. We employ a family of sufficiently general parametric models, the generalized odds-rate class of regression models, for the underlying incubation period and its correlation with covariates. In simulation studies, we assess the finite sample performance of the model fitting and hazard function estimation. The proposed method is illustrated on data from the HIV/AIDS study on injection drug users admitted to a detoxification program in Badalona, Spain.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  generalized odd rate class of models; incubation period of an infectious disease; interval censoring; left truncation; uncertain initiating event

Mesh:

Year:  2020        PMID: 33086432      PMCID: PMC7770078          DOI: 10.1002/sim.8774

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  A parametric survival model with an interval-censored covariate.

Authors:  Klaus Langohr; Guadalupe Gómez; Robert Muga
Journal:  Stat Med       Date:  2004-10-30       Impact factor: 2.373

2.  Estimating the AIDS incubation period from a prevalent cohort.

Authors:  J M Kuo; J M Taylor; R Detels
Journal:  Am J Epidemiol       Date:  1991-05-15       Impact factor: 4.897

3.  The distribution of incubation periods of infectious disease.

Authors:  P E SARTWELL
Journal:  Am J Hyg       Date:  1950-05

4.  Models for the incubation of AIDS and variations according to age and period.

Authors:  A Muñoz; J Xu
Journal:  Stat Med       Date:  1996 Nov 15-30       Impact factor: 2.373

5.  Estimating the Distribution of the Incubation Periods of Human Avian Influenza A(H7N9) Virus Infections.

Authors:  Victor Virlogeux; Ming Li; Tim K Tsang; Luzhao Feng; Vicky J Fang; Hui Jiang; Peng Wu; Jiandong Zheng; Eric H Y Lau; Yu Cao; Ying Qin; Qiaohong Liao; Hongjie Yu; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2015-09-26       Impact factor: 4.897

6.  Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.

Authors:  Manuela García de la Hera; Inmaculada Ferreros; Julia del Amo; Patricia García de Olalla; Santiago Pérez Hoyos; Roberto Muga; Jorge del Romero; Rafael Guerrero; Ildefonso Hernández-Aguado
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

7.  MODELING LEFT-TRUNCATED AND RIGHT-CENSORED SURVIVAL DATA WITH LONGITUDINAL COVARIATES.

Authors:  Yu-Ru Su; Jane-Ling Wang
Journal:  Ann Stat       Date:  2012-09-05       Impact factor: 4.028

8.  Statistical methods for analyzing right-censored length-biased data under cox model.

Authors:  Jing Qin; Yu Shen
Journal:  Biometrics       Date:  2009-06-12       Impact factor: 2.571

Review 9.  Epidemiological and genetic analysis of severe acute respiratory syndrome.

Authors:  Christl A Donnelly; Matthew C Fisher; Christophe Fraser; Azra C Ghani; Steven Riley; Neil M Ferguson; Roy M Anderson
Journal:  Lancet Infect Dis       Date:  2004-11       Impact factor: 25.071

10.  The incubation periods of Dengue viruses.

Authors:  Miranda Chan; Michael A Johansson
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.